Bruker reports mixed Q4 results; initiates FY26 outlook
Source: SeekingAlpha
2026-02-12 07:08:54 ET
More on Bruker
- Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Bruker Corporation (BRKR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Bruker: Attractive Valuation Ahead Of An Earnings Inflection
- Bruker Q4 2025 Earnings Preview
- Bruker secures $500M in multi-year MRI superconductor orders
Read the full article on Seeking Alpha
For further details see:
Bruker reports mixed Q4 results; initiates FY26 outlook
Bruker Corporation
NASDAQ: BRKR
BRKR Trading
0.19% G/L:
$36.61 Last:
433,317 Volume:
$37.36 Open:
BRKR Latest News
February 25, 2026 07:00:00 am
Bruker Accelerates the Future of Diagnostic and Prognostic Spatial Proteomics with the Launch of CellScape XR
February 24, 2026 07:00:00 am
Bruker Expands Collaboration with Noetik to Advance Tissue Foundational Models for Translational and Therapeutic Applications
BRKR Stock Data
$6,342,783,056
108,941,800
0.01%
138
N/A
Biotechnology & Life Sciences
Healthcare
US
Billerica
